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Abstract 
The aim of our work was to analyze the effects on blood sugar through the calculation of the 
glycemic score (GS) of 10 different high-protein-low-carbohydrates proprietary foods which 
are commonly used as meals during very low carbohydrate ketogenic diet or during low 
carbohydrate diet. 14 healthy female tested the glycemic response curve elicited by 1000 Kj 
of glucose three times within 3 weeks period (1 test each week) compared to each of the 10 
test-foods once on separate days twice a week. After determining the GS of each food in 
each individual, the mean GS of each test food was calculated. All test foods, compared to 
glucose, produced a significantly lower glycemic response . The GS of all test foods resulted 
lower than 25 and the difference between the mean glycemia after the intake of glucose 
(mean 122 ±15 mg/dl) and after the intake of the sweet test foods (mean 89 ± 7 mg/dl) was 
of 33 mg/dl (P<0.001), whereas that after the intake of glucose and the savory test foods 
(mean 91 ± 8 mg/dl ) was of 31mg/dl (P<0.001). We can conclude that the reformulation of 
ultra-processed ready-to-consume foods in a low carbohydrate, high protein version can 
produce a significant low glycemic response while maintaining the valued ready-to-use 
format and high palatability demanded by consumers. The low impact on postprandial 
glycemia and the nutritional characteristics of these proprietary foods make them useful both 
in weight control and in diabetes care dietary management. 
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INTRODUCTION 
 
Despite being considered a “preventible disease” by the World Health Organization, obesity 
is rising in both, high income and low income countries.1 Moreover overweightness and 
obesity are one of the majour causes of the woldwide burden of the four main non-
communicable diseases (NCDs): cardiovascular (CV) diseases, chronic respiratory 
diseases, cancers and diabetes melitus (DM). 2 
Amongst multiple reasons involved in the onset of overweight and obesity, nutrition appears 
to be the most important one.3 However, research has yet to produce a generally accepted 
nutritional approach.4 Populations experiencing an increase in obesity and CV diseases 
show common eating and drinking habits, notably a general decrease in minimally 
processed foods intake and in an increase in the consumption of ultra-processed ready-to-
consume products. These foods, based on the accepted definition acknowledged by the 
Pan American Health Organization5, are “industrial formulations manufactured from 
substances derived from foods or synthesized from other organic sources. (…) Most of these 
products contain little or no whole food. They are ready-to-consume or ready-to heat, and 
thus require little or no culinary preparation”. Examples of ultra-processed foods are savory 
and sweet snacks, ice-cream, frozen and chilled ready meals and soft drinks5 and they seem 
to be the cause of the extra daily diet calory intake of both, the young and the older 
populations.6 Ultra-processed ready-to-consume products present particular characteristics, 
which make them extremely profitable for producers and retailers and highly attractive for 
consumers. For example, consumers purchase them because they commonly require a 
minimal culinary action, they are flavoursome and relatively inexpensive. However, when 
analyzing ultra-processed products less protein, potassium and dietary fiber and more free 
sugar, total saturated and trans-unsaturated fats and sodium are generally evident  when 
compared to traditional foods.7,8  
All these characteristics appear to be linked to the burden of obesity and metabolic 
syndrome (MetS).6 A potential solution to this scenario could be to review ultra-processed, 
ready-to-consume products by  reduction of their sugar and fat contents. A particular kind of 
these new ultra-processed ready-to-consume products are proprietary foods which are high 
in proteins and fibers and low in sugar and saturated fats. These are specifically designed 
for particular diets such as the ketogenic regimen, but are successfully used also in more 
easy low carbohydrate diet as snacks or meal replacements.9 During ketosis, carbohydrate 
(CHO) intake must be under 30g/day10,11 and in previous studies 4,9, we demonstrated that 
these special foods, which mimic the taste and aspect of high content CHO foods but are 
low in sugar and high in protein content were able to increase the compliance of subjects to 
the ketogenic diet. Moreover, after the termination of a very low CHO ketogenic diet 
(VLCKD) intervention, patients tended to maintain the consumption of those proprietary 
foods during the day (usually at breakfast or during breaks). This can be considered a 
postive change of behaviour, since it is known that meal replacement during the 
maintenance phase is useful to prevent weight regain.12 During a VLCKD it is mandatory to 
maintain a low level of glycemia (about 80-90 mg/dL) to avoid insulin spikes13. This condition 
allows subjects to improve their fat oxidation as demonstrated by Paoli et al.14 and by 
Tagliabue et al.15 
Another important aspect of a VLCKD is the influence of such dietary regime on the 
perception of hunger.16 It has been suggested that ketone bodies reduce hunger through 
different and complex mechanisms 17; on the other side it is known that post prandial glucose 
and insuline spikes, tipically produced after the intake of traditional ultra-processed products 
which usually show a high glycemic index (GI)5 elicit food craving and overeating, with a 
preference for high-GI carbohydrates18, a phenomenon defined as the CHO-craving 
effect.19. Conversely, the consumption of non-processed foods low in simple sugars may 
ameliorate overeating and facilitate the maintenance of a healthy weight.18 
The above positive changes necassitates the need to analyze the effect of different high-
protein-low-CHO proprietary foods which are commonly used during VLCKD or low CHO 
diet (LCD) on glycemia compared to glucose.  
 
MATERIAL AND METHODS 
Subjects were recruited via advertisement placed in two pharmacies located in the province 
of Vicenza (Veneto, Italy). Exclusion criteria for this study were the presence of diabetes or 
pre-diabetes, being on a food diet and females who where either pregnant or breast-feeding. 
After a pre-selectin process of 32 participats, 14 females were eligible to participate in the 
present study (mean age: 42±13, mean weight: 72±21kg, mean BMI: 26±7). Participants 
were required to report any change of daily habits, such as engaging in a new exercise 
program, new pharmaceutical interventions or engaging in other than the present diets 
during the experimental phase which would have resulted in a study exclusion. The study 
was approved by the Ethical Board of the University of Padova, Department of Biomedical 
Sciences and conformed to standards for the use of human subjects in research as outlined 
in the Declaration of Helsinki. Investigators explained the purpose of the study, the protocol 
to be followed and the experimental procedures to be used prior to the start of the study. 
Subjects were required to sign a participation consent form and did not receive any monetary 
compensation. 
Subjects were tested for indivdual glycemic response curves elicited by the ingestion of 
1000 Kj of glucose three times within a 3 week period (1 test per week) and that of each of 
10 high-protein-low-CHO proprietary test foods once on separate days twice a week. Tests 
were performed in the morning after a 10-12 hours overnight-fast. Subjects were asked to 
have a regular meal, not to consume any alcohol and to avoid any unaccustomed exercise 
the night before tests. During the study period, participants maintained a constant foods 
supply, without changing their usual eating habits. 
*** FIGURE 1 HERE*** 
Fingertip capillary blood samples were collected in the fasted state and after 15, 30, 45, 60, 
90, and 120 min after starting to eat, changing the finger each time to avoid traumatization 
of the skin. The puncture was performed with the lancet Accu-Check Safe-T-Pro Plus 
(Roche Diagnostics, Basel, Switzerland) and blood was collected directly and immediately 
analysed using test strip Reflotron®  Glucose.20-22 Postprandial effect of sugar content on 
glycemia is commonly defined through three methods: the glycemic index (GI),  the glycemic 
load (GL) and the glycemic score (GS). 
The GI method was developed to rank foods according to the extent to which they increase 
blood sugar concentrations 23 and it is a number which ranges from 0 to 100, where 100 
represents the GI of the reference food glucose. To calculate the GI of a particular food, the 
area under the curve (AUC) of the rise in blood sugar for a 2 hour postprandial period is 
calculated. This value is consequently expressed  as a percentage of the incremental AUC 
following the consumption of a reference food (commonly white bread or glucose) consumed 
by the same person on a different day. 24 
The test food and the reference food must contain the same amount of available CHO (25g 
or 50g) and the individual has to perform the test under standardized conditions. 
GI= 
120 min iAUC(blood sugar) for portion size of test foods containing 50g (or 25g) of available carbohydrate  
120 min iAUC (blood sugar)for portion size of reference food containing 50g (or 25g) of available carbohydrate 
 x 100 
120 min iAUC(blood sugar) for portion size of test foods containing 50g (or 25g) of available carbohydrate  
120 min iAUC (blood sugar)for portion size of reference food containing 50g (or 25g) of available carbohydrate 
The GL 
method takes into account not only the magnitude of the glucose blood spike, but also the 
content (grams) of CHO in the portion of food consumed and it is calculated as the 
mathematical product of the GI for the available CHO content of the food. 25  
GL= 
GI (test food) X available grams of CHO in the quantity of test food consumed
100
  
GI (test food) X available grams of CHO in the quantity of test food consumed
100
 The GS method tests the glycemic 
response after the ingestion of low CHO foods and differs from the GI as it does not compare 
a standard amount of available CHO.  
However it compares the effect on glycemia of the same amount of a 1000 KJ portion of the 
test food to  the reference food. 25  
GS=  
120 min iAUC(blood sugar) for 1000 kJ test food
120 min i AUC(blood sugar)for 1000 KJ reference glucose
 x 100  
120 min iAUC(blood sugar) for 1000 kJ test food
120 min i AUC(blood sugar)for 1000 KJ reference glucose
Due to the very low CHO content of the tested 
foods and due to the quantity of food required to  reach the 25g of available CHO for the 
calculation of GI being too large, the present study utilised the GS method. 25 
Each tested food was served as a 1000 KJ portion with 220 ml warm (no sugar) tea for a 
better compliance of subjects in cold winter mornings after an overnight fast (tea doesn’t 
alter the incremental area under the glycaemic response curve 26) and consumed within a 
period of 10 minute. The present study tested 10 proprietary foods selected from the product 
range of Tisanoreica® snacks and meals (Gianluca Mech S.p.A., Asigliano Veneto, Vicenza, 
Italy). These are ready-to-consume foods high in protein and fiber content and low in CHO 
content designed to be consumed during a VLCKD or a LCD regimen.4, 9, 27. 
Among the products selected, six of them were sweet [chocolate biscuits CB (Cioco-Mech); 
chocolate and hazelnut balls CHB (Bon Mech); apple-cinnamon biscuits ACB (T-Biscuit); 
chocolate-almonds-pistachio bar CAPB (T-Smart); nuts and chocolate muffin NCM (T-
Muffin); chocolate drink CD (Cocoa Drink)]. The other four products tested were savory [two 
different types of pasta P1 (Original Tisanopast) and P2 (Tisanopast Style), the rosemary 
breadsticks RB (T-Smech) and the pizza dough PD (Pizza Dough)] (Table 1). Glucose  was 
used as reference food. This was dissolved in 220 ml of water and served as 1000 kj portions 
(15.68 kJ/g)28 and had to be consumed within a 10 minute period. 
*** table 1 here *** 
All statistical analyses were performed using package GraphPad Prism version 6.00 for 
Mac, GraphPad Software, San Diego, CA, USA.The AUC values above the fasting glucose 
concentration for each test food and for the reference food were used to calculate the GS 
of each test food and assessed using a XY data table by selecting the AUC analysis. The 
effect of each test food on glycemia compared to that of the reference food over time was 
assessed using a mixed model ANOVA (time x treatment). A post hoc Sidak’s multiple 
comparison test was performed.  
In order to select those test foods with a significant difference of blood sugar values 
compared to the other test foods,  a two-way repeated measure ANOVA (time vs nominal 
variables test foods vs measures) was performed. Each raw represented a different time 
point, so matched values were stucked into a subcolum. Tukey’s multiple comparison test 
was chosen in order to compare columns within each raw. 
A bivariate analysis was used to test, through a linear regression analysis, the significance 
of the associations between GS and sugars, protein and fiber in the 10 foods tested. An 
alpha level of p < 0.05 was used to denote a significant effect. 
 
RESULTS 
 
Mean GS, mean glycemia and mean glycemia in the different time points of the ten test 
foods and the reference food among the subjects tested are listed in Table 2. 
Mean glycemia after taking the reference food glucose resulted being 122 ±15 mg/dl, that 
after taking the sweet test foods was 89 ± 7 mg/dl and that after ingestion of the savory test 
foods was 91 ± 8 mg/dl.  
Figure 2 shows the mean blood sugar trend comparison at the different time points between 
glucose and sweet test foods, whereas Figure 3 shows that between glucose and savory 
test foods. After the ingestion of all sweet and savory test foods, the blood sugar showed 
always a significantly lower trend compared to that after the intake of the reference food 
glucose after 15, 30, 45, 60 and 90 minutes, though several test foods (CHB, CAPB, NCM, 
ACB, PD and RB) were able to maintain this significance even after 120 minutes.  
***Figure 2 here** 
**Figure 3 here** 
Figure 4 shows the blood sugar trend comparison between sweet test foods and savory test 
foods. The mean blood sugar trends comparison at the seven different time points 
highlighted a significant higher increase of glycemia particularly 15 and 30 minutes after 
taking the chocolate and hazelnut balls CHB and the two kind of pasta P1 and P2 compared 
to the other test foods (Figure 4). 
**Figure 4 here** 
In particular, the mean glycemia increased significantly 15 min and 30 min after the intake 
of CHB compared to the mean glycemia after the ingestion of the chocolate biscuits CB, the 
chocolate-almonds-pistachio bar CAPB, the rosemary breadsticks RB  and the pizza dough 
PD (Figure 5). 
**Figure 5 here**  
After the intake of P2 the mean glycemia increased significantly after 15 min and 30 min. 
compared to the sweet test foods CB, CAPB and NCM and to the savory test foods PD and 
SB (Figure 6).  
**Figure 6 here** 
After the intake of P1 the mean glycemia increased significantly after 15 min and 30 min. 
compared to the sweet test foods CB and CAPB and to the savory test foods PD and SB 
(Figure 7).  
**Figure 7 here** 
The statistical two way anova analysis of the trend of blood sugar from before starting to eat 
up to two hours after the intake of the reference food or of the test foods shows that, on 
average, the 40% of the total variation observed is due to the difference between the foods 
eaten (glucose or test foods). This result shows that, among all the "Sources of Variation" 
analized (Time, Food, Subjects), the variable “Food” appears to be the one that explains 
most of the variation observed between the blood sugar trends after the intake of test foods 
and the blood sugar trend after the intake of the reference food. 
The results didn’t show any correlation between GS and fiber content (r=-0.08; P=0.37), 
neither between GS and sugar content (r= 0.17; P=0.09), nor between GS and protein 
content (Figure 8). 
**Figure 8 here**  
The average GS of each test food, calculated as the mean of GS values of each test food 
resulted from every subjects, was always less than 25 compared to the GS reference value 
of glucose which is 100 (Table 2). The test food with the highest GS is the sweet test food 
Bon Mech with a GS of 23. The test food with the lowest GS are the sweet test food Cioco 
Mech and  T-Smart, with a GS of 14. 
*** Table 2 here *** 
 
DISCUSSION 
In this study the GS of 10 proprietary foods high in proteins and fibers and low in sugars and 
saturated fats were tested. These proprietary foods claim to replicate the taste and aspect 
of high CHO foods and are commonly used as meals during VLCKD regimes.  In our study 
the products tested showed a significant lower blood sugar response and lower GS 
compared to an isoenergetic amount of glucose. Amongst the six sweet and four savory test 
foods, the sweet little balls with chocolate and hazelnut CHB showed the highest GS (GS= 
23). This  result is consistent with the higher quantity of available sugars of CHB compared 
to the other test foods. The chocolate biscuits CB and the bar with chocolate, almonds and 
pistachio CAPB  had the lowest GS of 14. This GS value is, according to the data avalable 
25, similar to the GS of  a low fat processed cheese. 
The macronutrient composition is important for glucose response, with carbohydrate as the 
food component which acts directly on glycemia, rising it and stimulating insulin secretion. 
However, even if carbohydrate counting is still the basis for insulin dose adjustment in 
diabetes care management,29 data show 25 that sugar content could be a stronger predictor 
of the observed glucose response compared to carbohydrate. Other studies show that the 
structure of carbohydrates should also be keep in consideration: a disrupted structure, 
typical of processed whole grains, has a different effect on glycemia compared to intact 
grains. 30. 
Considering fibers, even if there is a strong evidence supporting their beneficial effect in 
reducing disease risk 25, only soluble fibers with gel-forming properties show a 
distinguishable effect for glycemic control.31, 32 
The present study, according to these data, doesn’t show  any significant relation between 
GS and fiber content, but, differently from them, it doesn’t show any correlations between 
GS and sugar content (Figure 8). This  conflicting result  might be due to the very low quantity 
of available sugars in the test foods. Finally, protein content, despite being considered 
predictive for the GS25, did not show such correlation in this study. 
The low postprandial glycemia produced by the proprietary foods tested is an important 
factor, since ultra-processed ready to consume products are commonly high in simple 
sugars that negatively affect a number of health parameters. Postprandial hyperglycemia 
and compensatory hypoglycemia are factors linked to the development of diabetes and 
cardiovascular diseases 33. Furthermore, the consumption of high-sugar snacks seems to 
be the main cause for the increase in intrahepatic triglyceride content (IHTG)34. Finally, the 
usual rapid and high glycemic peak caused by ultra-processed products, together with their 
lack in fiber, proteins and water, triggers an excessive consumption19, 35.  
Sugar is rapidly absorbed and produces a consequent high blood sugar spike which acts 
centrally, increasing the production and utilization of dopamine, imitating the typical 
neuromodulation of addictive substances.36  
The abuse of high sugary ultra-processed foods leads to the synthesis and the accumulation 
of fat and weight gain 8, which increase the risk for obesity and MetS. The MetS is, according 
to the World Health Organization definition, the symultaneous presence of insulin resistance 
along with two other risk factors from high blood pressure, raised triglycerides, low HDL and 
increased BMI (or increased waist:hip ratio) and microalbuminuria.37 The prevalence of this 
desease, once suggested to be exclusive of adulthood, is  becoming a major worldwide 
concern among both children and adolescents 38, 39 and the consumption of ultra-processed 
foods is considered an important risk factor for its development.40 Bielemann et al.41 recently 
demonstrated that ultra-processed foods were responsible for the 50% of the daily caloric 
intake among a cohort of 23 year old participants in Brazil. Interestingly, the household 
availability of ultra-processed ready-to-eat foods was associated with a low percentage of 
proteins and fibers intake. 
Appetite control isn’t related only to glucose content and post prandial glycemia, but also to 
othere factors42 among which the reward system in the brain, aside from the homeostatic 
control by the hypothalamus, has been the focus of recent interest, since food rewards is a 
goal that drives both appetite and eating.43, 44   
Stated that the larger the portion size the more food is eaten 44  and that eating is only 
indirectly related to energy balancing since it seems that we eat essentially for pleasure,44 
these low calorie proprietary foods could help to reduce energy intake, useful for a better 
weight maintenance or a more successfully weight loss. Moreover, since high energy dense 
foods have the lowest satiating capacity even if they usually have a high palatability,44 the 
high level of proteins and fibers and the high palatability, despite the low sugar content, of 
these new ultra-processed foods, are important features which contribute to both food 
reward and satiety.45  
The tendency to prefer sugary fatty foods over savory foods is considered innate and 
universal and finds its roots in very important adaptive processes: a bitter taste is considered 
predictive of toxicity and then avoided (alkaloids, glycosides and other toxins have a bitter 
taste), whilst the sweet taste is associated with energy and nourishment 46. Although it is 
recognized that the VLCKDs lead to greater weight losses compared to a low-calorie 
balanced diet at least in the short term,47 subjects with a sweet food preference may not 
adhere to this diet because of the lack of their prefered taste.48, 49 A VLCKD that includes 
these proprietary foods which imitate taste and aspects of high CHO food but have a low 
glucose content can consequently produce a higher level of adherence and a reduced drop-
out rate.4, 50 
Sweet foods are usually rich in refined CHO, have a high GI and are related with an 
increased risk for overweight, obesity51 and Type 2 DM.52 Type 2 DM (T2DM) is increasing 
among young people 53 and a dietary management is the most important factor to be 
considered to prevent the progression of impaired glucose tolerance to clinical DM. The 
dietary management is also important to minimize the glycemic variability, which is the 
measure of the of blood sugar concentration changes over time.54 An uncontrolled blood 
sugar concentration is the major risk factor in the development of T2DM complications such 
as retinopaty, neuropathy, nephropathy and cardiovascular diseases.55-58 It is important to 
make healthier nutritional choices to prevent these complications, which are associated with 
high economic, social and personal costs. Low-CHO high-protein diets help to normalize 
glycemic fluctuations in T2DM management.59 As suggested by the  European Association 
for the Study of Diabetes (EASD) dietary fibers can further positively influence blood sugar 
variability. The EASD consequently recommends the  the consumption of high-fiber, low-GI 
foods as CHO source.54 
Dietary amino acids contribute to the de novo synthesis of glucose through gluconeogenesis 
and participate in the re-cycling of glucose carbon via the glucose-alanine cycle.60 However, 
dietary proteins have a minimal impact on glycemia and insulin secretion compared to CHOs 
61 and a high-quality protein supplementation has been suggested during a weight loss 
program to preserve muscle mass, to improve glycemic regulation and to 
maintenaneuglycemia.62, 63 The ten proprietary food tested in the present study are 
formulated with whey proteins. These, due to  their high content of leucine which promotes 
muscle mass synthesis and their fast digestion and delivery of aminoacids in the circulation, 
are consequently considered the best type of proteins. 62  
Moreover, whey protein decrease appetite better than other types of proteins 64  and 
increase satiety through an increase of the release of of CCK and GLP-1 and a reduction of 
ghrelin levels.65  
The sweet proprietary foods tested in the present study also contained low-calorie 
sweeteners. These are compounds able to stimulate, in the same way as sugar does, the 
sweet taste receptors. 66 
Unlike sugar, low-calorie sweeteners do not release energy and for this reason they are 
used in weight loss programs, even though perceived as controversial by the scientific 
community with respect to their possible adverse metabolic effects, such as increase of 
appetite, weight gain and metabolic disorders.67-69 However, more studies are required to 
confirm these negative suggestions, since a recent review shows that there is no evidence 
for a limitation of their use to reduce energy intake.70 The same author states that our 
congenitally liking for sweetness implies that the reward value from sugar and low-calorie 
sweeteners is the same, but low calorie sweeteners should be preferred, since they avoid 
the high-calorie-intake side effect of sugar.44 These compounds could be useful in the 
prevention of overweightness and obesity in populations which are less sensitive to 
sweetness, predisposing them to consume more sugar in order to have the same ‘taste 
sensation’ as people more sensitive to sweetness.71 Nowadays low-calorie sweeteners are 
important tools in DM management, where the dietary adherence is amongst the most 
difficult cornerstones72, especially for children and adolescents with T2DM who suffer from 
the perceived lack of normality in their diet and consequenlty desire non-recommended 
sweet foods.73 
Ready-to-consume proprietary foods, high in good quality proteins and fibers, could improve 
both, the diet of young people, and the diet of T2DM patients. In the former population this 
could prevent them from eating high sugary fatty foods, predisposing them to the 
development of T2DM and in the latter to minimize blood sugar variability that often 
complicates the pathology. The ten proprietary foods tested showed a significant lower 
glycemia compared to the standard food glucose and their GS resulted always lower than 
25. This low glycemic response, together with their valuable ready-to-use format, make 
these proprietary foods a valid tool both during weight management and weight loss 
programs, facilitating the adherence to a low CHO diet of people who tend to have a high 
preference for sweet foods. 
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